Developmental differences in megakaryocyte maturation are determined by the microenvironment

Stem Cells

Volumn 23, Issue 9, 2005, Pages 1400-1408

  Slayton, William B ^a,b,c   Wainman, David A ^b   Li, Xiao Miao ^a   Hu, Zhongbo ^a   Jotwani, Anil ^a   Cogle, Christopher R ^b   Walker, Danielle ^a   Fisher, Robert C ^b   Wingard, John R ^a   Scott, Edward W ^b   Sola, Martha C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Adult bone marrow stem cells; Development; Megakaryocytopoiesis; Thrombopoiesis; Umbilical cord blood

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL MATURATION; CONTROLLED STUDY; MEGAKARYOCYTE; MOUSE; NONHUMAN; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; TRANSGENIC MOUSE; UMBILICAL CORD BLOOD;

AGE FACTORS; ANIMALS; DNA; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET TRANSFUSION; PLOIDIES; STEM CELLS; THROMBOPOIESIS;

MUS MUSCULUS;

EID: 27144556986     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0373     Document Type: Article

References (35)

1. Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplant. Transfus Clin Biol 2001;8:146-154.
2. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-1822.
3. Couban S, Simpson DR, Barnett MJ et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002;100:1525-1531.
4. Sanz GF, Saavedra S, Planelles D et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001;98:2332-2338.
5. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 2003;127:316-320.
6. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-1869.
7. Rozman P. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transpl Immunol 2002;10:165-181.
8. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7:290-302.
9. Dutta U, Raina V, Garg PK et al. A prospective study on the incidence of hepatitis B & C infections amongst patients with lymphoproliferative disorders. Indian J Med Res 1998;107:78-82.
10. Bornstein R, Garcia-Vela J, Gilsanz F et al. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol 2001;114:458-465.
11. + cells are correlated with different levels of platelet release. Blood 2002;99:888-897.
12. Schipper LF, Brand A, Reniers N et al. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol 2003;31:324-330.
13. Miyazaki R, Ogata H, Iguchi T et al. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol 2000;108:602-609.
14. Sola MC, Rimsza LM. Mechanisms underlying thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 2002;91:66-73.
15. Sola MC, Calhoun DA, Hutson AD et al. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999;104:90-92.
16. Nakorn TN, Miyamoto T, Weissman IL. Characterization of mouse clonogenic megakaryocyte progenitors. Proc Natl Acad Sci U S A 2003;100:205-210.
17. Hadjantonakis AK, Gertsenstein M, Ikawa M et al. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 1998;76:79-90.
18. Jackson CW, Brown LK, Somerville BC et al. Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions. Blood 1984;63:768-778.
19. de Alarcon PA, Graeve JL. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 1996;39:166-170.
20. Debili N, Issaad C, Masse JM et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992;80:3022-3035.
21. Kuwaki T, Hagiwara T, Yuki C et al. Quantitative analysis of thrombopoietin receptors on human megakaryocytes. FEBS Lett 1998;427:46-50.
22. van den Oudenrijn S, von dem Borne AE, de Haas M. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol 2000;28:1054-l061.
23. Avecilla ST, Hattori K, Heissig B et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004;10:64-71.
24. Guerriero R, Mattia G, Testa U et al. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 2001;97:2587-2595.
25. Ponomaryov T, Peled A, Petit I et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000;106:1331-1339.
26. Sola MC, Christensen RD, Du Y et al. Neonates fail to increase their marrow megakaryocyte mass in response to thrombocytopenia. Pediatr Res 2002;51:242a.
27. Harrison DE, Astle CM. Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood. Blood 1997;90:174-181.
28. Morrison SJ, Hemmati HD, Wandycz AM et al. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci U S A 1995;92:10302-10306.
29. Wolf NS, Bertoncello I, Jiang D et al. Developmental hematopoiesis from prenatal to young-adult life in the mouse model. Exp Hematol 1995;23:142-146.
30. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-1618.
31. Benito AI, Diaz MA, Gonzalez-Vicent M et al. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004;33:675-690.
32. Adams GB, Chabner KT, Foxall RB et al. Heterologous cells cooperate to augment stem cell migration, homing, and engraftment. Blood 2003;101:45-51.
33. Szilvassy SJ, Meyerrose TE, Ragland PL et al. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 2001;98:2108-2115.
34. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344:1870-1871.
35. + progenitor cells. J Immunol 2002;169:7000-7008.